PURPOSE: Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) was utilized in postmortem imaging of gadolinium (Gd) spatial distribution in a mouse tumor model postadministration of PEGylated Gd liposomal nanoparticles. PROCEDURES: PEGylated liposomal nanoparticles were formulated using a paramagnetic lipid incorporating Gd, in addition to a fluorescent lipid, and injected intravenously into Balb/C nude mice bearing IGROV-1 tumors. At postinjection (2 h), the tumors and selective organs were imaged by magnetic resonance imaging (MRI) and, after excision, by histology and LA-ICP-MS. RESULTS: The presence of Gd within tumor tissue was confirmed by LA-ICP-MS and when correlated to histology was found to be prevalent in regions of higher vascularity. The presence of Gd in the kidneys was also confirmed. CONCLUSIONS: We have demonstrated, in a novel manner, the use of LA-ICP-MS for the spatial detection of Gd in tumor tissue. LA-ICP-MS is valuable in providing spatio-specific information of MRI contrast agents and more importantly Gd in tumor tissue.
PURPOSE: Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) was utilized in postmortem imaging of gadolinium (Gd) spatial distribution in a mousetumor model postadministration of PEGylated Gd liposomal nanoparticles. PROCEDURES: PEGylated liposomal nanoparticles were formulated using a paramagnetic lipid incorporating Gd, in addition to a fluorescent lipid, and injected intravenously into Balb/C nude mice bearing IGROV-1 tumors. At postinjection (2 h), the tumors and selective organs were imaged by magnetic resonance imaging (MRI) and, after excision, by histology and LA-ICP-MS. RESULTS: The presence of Gd within tumor tissue was confirmed by LA-ICP-MS and when correlated to histology was found to be prevalent in regions of higher vascularity. The presence of Gd in the kidneys was also confirmed. CONCLUSIONS: We have demonstrated, in a novel manner, the use of LA-ICP-MS for the spatial detection of Gd in tumor tissue. LA-ICP-MS is valuable in providing spatio-specific information of MRI contrast agents and more importantly Gd in tumor tissue.
Authors: Robert W Hutchinson; Alan G Cox; Cameron W McLeod; Peter S Marshall; Alex Harper; Emma L Dawson; David R Howlett Journal: Anal Biochem Date: 2005-09-19 Impact factor: 3.365
Authors: Nazila Kamaly; Tammy Kalber; Ayesha Ahmad; Morag H Oliver; Po-Wah So; Amy H Herlihy; Jimmy D Bell; Michael R Jorgensen; Andrew D Miller Journal: Bioconjug Chem Date: 2007-11-07 Impact factor: 4.774
Authors: J Dobrowolska; M Dehnhardt; A Matusch; M Zoriy; N Palomero-Gallagher; P Koscielniak; K Zilles; J S Becker Journal: Talanta Date: 2007-07-25 Impact factor: 6.057
Authors: Pablo A Valdés; Ziev B Moses; Anthony Kim; Clifford J Belden; Brian C Wilson; Keith D Paulsen; David W Roberts; Brent T Harris Journal: J Neuropathol Exp Neurol Date: 2012-09 Impact factor: 3.685
Authors: S Gokhan Elci; Bo Yan; Sung Tae Kim; Krishnendu Saha; Ying Jiang; Gunnar A Klemmer; Daniel F Moyano; Gulen Yesilbag Tonga; Vincent M Rotello; Richard W Vachet Journal: Analyst Date: 2016-03-16 Impact factor: 4.616
Authors: Nick Mitchell; Tammy L Kalber; Margaret S Cooper; Kavitha Sunassee; Samantha L Chalker; Karen P Shaw; Katherine L Ordidge; Adam Badar; Samuel M Janes; Philip J Blower; Mark F Lythgoe; Helen C Hailes; Alethea B Tabor Journal: Biomaterials Date: 2012-11-03 Impact factor: 12.479
Authors: Bhavesh D Kevadiya; Brendan Ottemann; Insiya Z Mukadam; Laura Castellanos; Kristen Sikora; James R Hilaire; Jatin Machhi; Jonathan Herskovitz; Dhruvkumar Soni; Mahmudul Hasan; Wenting Zhang; Sarella Anandakumar; Jered Garrison; JoEllyn McMillan; Benson Edagwa; R Lee Mosley; Richard W Vachet; Howard E Gendelman Journal: Theranostics Date: 2020-01-01 Impact factor: 11.556